BioPharm Communications

Articles

Engaging HCPs With KOL Videos

KOL Influence: Giving Brands a Trusted Voice

Escaping Digital Saturation: The Rebound of Print in HCP Marketing


Steve Carickhoff is President of BioPharm Communications where, over the past 10 years, he has helped lead the transformation of the agency into a omnichannel partner of choice. Previously Steve worked on the client side at Shire.

Rethinking Omnichannel Measurement

Orchestrated Storytelling Focused on User Experience

Nadia Khatri is a Director of Omnichannel Strategy at BioPharm Communications, seeking opportunities for growth across all categories in the pharmaceutical space. She is focused on understanding the digitization of healthcare and the implications of major market disruptions.

How non-endemic platforms can help brand teams amplify their use of KOLs in HCP outreach

Engaging and Educating HCPs with KOL-Based Paid Social

BioPharm Communications is an innovative omnichannel marketing solutions partner with a comprehensive portfolio of third-party promotional tools. BioPharm leverages a proprietary data-driven approach to campaign planning, development, and deployment.

While COVID-driven challenges remain many, so do the carryover opportunities to redefine HCP engagement and communication.

2021 Will Be Another Transformative Year for Digital Marketing

Marketers are working to reimagine how they leverage key opinion leader (KOL) support during COVID-19.

The Importance of Opinion Leader-Content in a Digital Transformation

Non-personal promotion is a foundational component of most brands’ omnichannel marketing strategy. 

The Non-Personal Promotion Equation


BioPharm Communications is the leading provider of data-driven, fully integrated multichannel marketing services to the pharmaceutical and biotech industries. They are actively working with 50+ pharma and biotech companies and have delivered multichannel campaigns for 200+ brands. Their Insights 360 proprietary database contains unparalleled behavioral data for more than 1.1 million US HCPs, learned through over 1,200 BioPharm campaigns. It serves as the foundation of their insights-driven approach to campaign planning, development, and deployment.   

The current COVID-19 pandemic has taken the world of HCP marketing and turned it upside down. Biopharma has had to make instantaneous decisions on how to market in this new environment, who to market to, which tactics to significantly increase, and which tactics to walk away from-all with no historical playbook. 